Decreased levels of guanosine 3′, 5′-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease-Reference-Cited by-同舟云学术

Decreased levels of guanosine 3′, 5′-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

Published:2015-05-13 Issue:4 Volume:41 Page:471-482
ISSN:0305-1846
Container-title:Neuropathology and Applied Neurobiology
language:en
Short-container-title:Neuropathol Appl Neurobiol

Author:

Ugarte Ana¹,Gil-Bea Francisco²,García-Barroso Carolina²,Cedazo-Minguez Ángel³,Ramírez M. Javier⁴,Franco Rafael⁵,García-Osta Ana²,Oyarzabal Julen¹,Cuadrado-Tejedor Mar²⁶

Affiliation:

1. Small Molecule Discovery Platform; Molecular Therapeutics Program; University of Navarra; Pamplona Spain

2. Neurobiology of Alzheimer's Disease; Neurosciences Division; Center for Applied Medical Research; CIMA; University of Navarra; Pamplona Spain

3. KI-Alzheimer's Disease Research Center; Department of Neurobiology; Care Sciences and Society; Karolinska Institutet; Huddinge Sweden

4. Department of Pharmacology; University of Navarra; Pamplona Spain

5. Department of Biochemistry and Molecular Biology; Universitat de Barcelona; Barcelona Spain

6. Department of Anatomy; University of Navarra; Pamplona Spain

Funder

FIMA (Spain)

FIS project

MINECO

Stockholm County Council

Karolinska Institutet

Swedish Brain Power

Margaretha af Ugglas stiftelsen

Swedish Alzheimer foundation

Publisher

Wiley

Subject

Physiology (medical),Neurology (clinical),Neurology,Histology,Pathology and Forensic Medicine

Reference40 articles.

1. Cyclic nucleotide research - still expanding after half a century;Beavo;Nat Rev Mol Cell Biol,2002

2. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling;Conti;Annu Rev Biochem,2007

3. cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour;Kleppisch;Handb Exp Pharmacol,2009

4. Phosphodiesterases as therapeutic targets for Alzheimer's disease;Garcia-Osta;ACS Chem Neurosci,2013

5. Selective phosphodiesterase inhibitors: a promising target for cognition enhancement;Reneerkens;Psychopharmacology (Berl),2009

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease;European Journal of Medicinal Chemistry;2024-12

2. Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy;Bioorganic Chemistry;2024-10

3. Advances in dual-targeting inhibitors of HDAC6 for cancer treatment;European Journal of Medicinal Chemistry;2024-09

4. Sildenafil Reverses the Neuropathological Alzheimer’s Disease Phenotype in Cholinergic-Like Neurons Carrying the Presenilin 1 E280A Mutation;Journal of Alzheimer's Disease;2024-05-14

5. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases;European Journal of Medicinal Chemistry;2024-05